Objective: The combined effects of limited food intake and OE treatment have been analysed in order to determine whether hypocaloric diets enhance the slimming effects of OE on mature overweight male rats. Two levels of dietary limitation at 50 and 25% of a standard intake were established, roughly corresponding to the human LCDs and VLCDs. Design: Wistar male rats (6 weeks old) were made overweight by a cafeteria diet. After transition to standard diet, they were subjected to food restriction: down to 50 or 25% with respect to the transition period. Half the animals were given daily oral gavages of 10 nmol/g oleoyl-estrone (OE), and the rest received only the vehicle during 10 days. Measurements: Changes in weight and body composition: water, lipid, protein or gross energy were determined by comparing the final pool size with that of day 0, calculated from the initial body weight and the composition of untreated rats. Energy and nitrogen balances were estimated. Plasma levels of metabolites and hormones were also measured. Results: OE induced changes in body composition similar to those elicited by a 50% reduction in food, with massive loss of lipid and energy. OE-treated rats ate less than the controls, but additional effects on body composition on reduced diet were minimal. OE improved metabolic homoeostasis: better maintained glycaemia, lower cholesterol and shallower hormonal changes, but at the expense of slightly increased protein mobilisation. Conclusions: The data presented suggest that no advantages are accomplished by combining OE treatment and hypocaloric diets compared with OE alone, at least under the experimental conditions tested, since the effects were not additive. Despite OE affecting food intake, mechanisms other than that are deemed responsible for the mobilisation of body fat, since intake alone cannot explain the effects on body weight, nor the metabolic and hormonal changes in OE-treated rats. It is concluded that the combination of food restriction and OE may result in unwanted increased protein mobilisation with no synergy between both slimming treatments.
Introduction
Food deprivation induces the rapid mobilisation of glycogen stores and the oxidation of protein as source of 3C fragments with which to sustain hepatic gluconeogenesis and thus help maintain glycaemia. 1 In a second phase, protein protection schemes take hold 2 preventing additional wasting and shifting the main energy source from glucose to fatty acids and ketone bodies. 3 This change is coupled to the progressive mobilisation of adipose tissue fat stores and the corresponding adaptation of muscle lipid and amino-acid metabolism, together with a marked decrease in energy expenditure 4 to save valuable (often irreplaceable) energy substrates. Oleoyl-estrone (OE) is a fat-mobilising hormone 5 produced by adipose tissue, which is carried by the plasma lipoproteins. 6 The oral administration of OE to lean, genetically obese or dietary-obese rodents induces a marked loss of body fat, 7, 8 primarily due to a decrease in voluntary food intake coupled with the maintenance of energy expenditure. 9 Glucose levels are maintained in spite of marked decreases in insulin and leptin, 10 a consequence of OE-elicited increase in insulin sensitivity/decrease in insulin resistance, 11 which results in the maintenance of liver glycogen stores regardless of the severe drainage of body energy. 10 Lipid mobilisation, however, does not massively increase circulating lipids, since lipid oxidation is also increased as shown by the lowering of the respiratory quotient, 5 and marked decrease in cholesterol levels 12 coupled with enhanced muscle lipoprotein lipase activity. 13 Human obesity has been traditionally treated with hypocaloric diets, since it is assumed that a decrease in energy intake must compel the body to mobilise its fat stores to cope with the energy imbalance; however, dieting tends to decrease energy expenditure, 14 which makes much harder to significantly affect the mass of stored fat. The considerable difficulty in shedding off fat through dieting is compounded by the recovery of energy stores when food availability is restablished. 15 Most antiobesity compounds are used in conjunction with hypocaloric diets, essentially to enhance their lipid-mobilising effects, to diminish the unwanted effects of limited food intake (i.e. hunger pangs, hypoglycaemia), to enhance energy expenditure to speed up the process of fat disposal, or to maintain the weight loss during and after treatment. 16 OE has been used, so far without association to limited food intake, both in rodents and humans, [17] [18] [19] since OE limits food intake by itself, and prevents the fall in energy expenditure 5, 11 that accompanies food deprivation. 4 In the present study, we have explored the combined effects of severely limited food intake and OE treatment, in order to determine whether hypocaloric diets enhance the slimming effects of OE on mature overweight male rats. Since a typical hypocaloric diet provides 40-50% of a standard diet's energy, and a very low-calorie diet provides about half of that, we established two levels of dietary limitation, theoretically at 50 and 25% of a standard intake, roughly corresponding to the human low-calorie diets and very low-calorie diets.
Materials and methods
Male Wistar rats (6 weeks old) of Harlan-Interfauna (Sant Feliu de Codines, Spain) stock were used. They were kept in collective cages (two rats in each) in a light cycle, temperature, ventilation and humidity-controlled environment. All animal-handling procedures were approved by the Ethics and Animal Care Committee of the University of Barcelona, following the EU-, Spanish-, and Catalan Government-established norms and procedures. A fattening protocol previously published 20 was used; the animals were fed for 5 weeks with a modified cafeteria diet 11, 17 (fattening period). Afterwards, they were transferred to wire mesh-bottomed cages and were maintained for 5 days exclusively on a pellet ('maintenance' type, from Panlab, Barcelona, Spain) ad libitum diet (stabilisation period). Then, when the rat age was 12 weeks, they were randomly distributed in six experimental groups for the experimental phase of the study, which lasted 10 days. Initial body weights and food consumption during the different phases can be seen in Table 1 . Half the animals were given a daily gavage of Limited food intake and oleoyl-estrone MM Romero et al 0.2 ml of sunflower oil by means of a gastric tube, the other half received the same gavage containing a dose of 10 nmol/g OE (OED, Barcelona, Spain). The animals were subdivided into three diet groups:
1. AL, fed ad libitum; the rats had unrestricted access to pellet food and water; 2. HEA, or half energy availability, that is, 50% dietary restriction, these animals had access to a fixed amount of pellet food, corresponding to half their mean food consumption during the stabilisation period, they had unrestricted access to water; 3. QEA, or quarter energy availability, that is, 75% dietary restriction, with access to only one-quarter of the mean food consumed during the stabilisation period.
Roughly, the HEA diet was considered akin to a 'human' LCD, and the QEA diet to a VLCD. An additional group of rats were killed just at the end of the stabilisation period, before the final gavage and diet-reduction experiment, in order to obtain the initial body composition data. Food consumption and body weight were measured daily in all the groups.
On day 10, the remaining rats were killed by decapitation. The blood was recovered and allowed to clot; the serum was stored at À801C until processed. The stomach and intestinal contents were discarded; the rat remains were autoclaved, homogenised and used for the estimation of water, protein, lipid and energy content as previously described: 11 water was estimated by differential weighing before and after desiccation at 1101C; protein was estimated from the N content (Kjeldahl, using the 1007 Digestor and 1002 Distilling Unit, both from a Tecator Kjeltec System, Höganäs, Sweden) and conversion of N content into protein equivalence; 21 lipid by trichloromethane: methanol extraction; 22 and energy using a bomb calorimeter (C-7000 Ika, Heitersheim, Germany). The final body composition was determined from the percentages of body components measured experimentally and the estimated 'in vivo' net body weight. For calculation of the body weight components' content of the group killed at the beginning of the study was used in conjunction with the initial body weight of each rat. Metabolisable energy content of the pellet food was estimated from the standard caloric equivalence of its assimilable components (154 g/kg crude protein, 605 g/kg carbohydrate, 29 g/kg lipid) and the assumed efficiency of the digestive process, giving a yield of 13.9 kJ/g. The total energy content of the pellet was estimated with the bomb calorimeter (16.5 kJ/g), which represents that only about 84% of the total energy contained in the pellet (including that of fibre) was assumed to be taken up and used by the rat. Total nitrogen content of the pellet was also measured (Kjeldahl): 23.6 g/kg, and used for the estimation of N intake (Ni).
Energy expenditure was calculated as energy intake (energy correlate of the food ingested) minus the energy accretion calculated as the difference in the energy content of controls and experimental groups corrected by initial body weight. All data were expressed as rates, that is, accretion in g/day or, in the case of energy, in power units (watt ¼ J/s).
Ni was estimated from the N content in the pellet, N accretion (Na) was determined from final N content and calculated initial N using the same reasoning described above for energy. Faecal N (Nf) was estimated by measuring (Kjeldahl) the N content of pooled droppings. It was assumed that the N excreted (Ne) was the difference:
The nitrogen excreted included urinary nitrogen and other N losses, such as the 'nitrogen gap'. 23 Serum samples were used for the estimation of glucose (Trinder glucose kit, Sigma), urea (kit B8035 from Menarini), triacylglycerols (kit 11528; Biosystems, Barcelona, Spain), total cholesterol (kit B7576; Menarini, Firenze, Italy), HDLcholesterol (precipitating kit CH204 from Randox, Crumlin, UK; and kit B7576 from Menarini), non-esterified fatty acids (NEFA) (kit NEFA-C; Wako, Richmond, VA, USA), 3-hydroxybutyrate (kit 0907979; Boehringer-Mannheim, Mannheim, Germany), creatinine (kit 30982; Menarini), aspartate transaminase (kit 51-25 Infinity AST reagent, Sigma Diagnostics, St Louis, MO, USA), alanine transaminase (kit 51-25 Infinity ALT reagent, Sigma Diagnostics), insulin (rat insulin RIA kit; Linco, St Louis, MO, USA), adiponectin (mouse adiponectin RIA, Linco), leptin (rat leptin RIA, Linco). Homeostasis model assessment method (HOMA score) was used to assess insulin resistance. 24, 25 Statistical comparison between groups was carried out using a two-way ANOVA program from the Statgraphics Plus v.2.1 (Manugistics, Rockville, MD, USA) software. Limited food intake and oleoyl-estrone MM Romero et al
Results
The daily food consumption of all rats during the 5-day stabilisation period was 14% lower than that of AL controls during the following 10 days, probably because of dietchange stress (Table 1 ). The use of the food consumption data during this period to determine the overall reduction in food available for the restricted groups resulted, thus, in a more severe food allocation reduction than expected, but in any case the data are comparable between similarly treated groups, and inter-comparable with human dietary restriction treatments too, in spite of the experimental results showing a more intense or longer incidence of dietary change-related stress than expected.
Control rats killed at the end of the stabilisation period (i.e. day 0 of the food-restriction study) had a mean composition of 580730 g/kg water, 17773 g/kg protein, and 212719 g/kg lipid; their energy content was 13.270.1 kJ/g. Figure 1 shows the changes in body weight experienced by the six experimental groups during the 10-day study period. Table 1 also presents the data for the previous fattening and stabilisation periods, as well as the rates of body weight change and food consumption by the different groups. Control AL rats slightly increased their body weight ( þ 1.8%) but had a higher food consumption than in the stabilisation period ( þ 16%). OE decreased food consumption by 24%, and body weight by 11%; these data were fairly similar to those of the rats with HEA, which decreased body weight by 13%. The combination of HEA and OE further decreased food intake (À57%) and body weight (À17%), a figure similar to that of the rats with QEA, which decreased body weight by 17%. Finally, the maximal loss of weight (À20%) was observed in the rats subjected QEA and OE treatment.
In all the groups, the OE-treated rats ate less than their matched diet controls, the difference was maximal for AL: 66%, but with HEA, OE-treated rats did not consume all food available, only 85% of their matched controls; the figure for QEA was 98%.
The changes in body composition induced by dietary restriction and OE treatment are presented in Table 2 . In the AL rats, the effects of OE were considerable, since in 10 days, differences of 7.5% in water pool, 4.7% in protein pool, 30.0% in lipid pool and 20.2% in total energy content were accumulated. However, the corresponding differences in the HEA rats were smaller: 5.7% in water pool, 1.4% in protein pool, À0.9% in lipid pool and 1.8% in total energy. Those obtained comparing the rats QEA groups were similar to the HEA data: 4.1% in water pool, 2.1% in protein pool, À1.7% in lipid pool and 2.0% in total energy.
Diet restriction resulted in significant effects on weight, water and protein content, those on lipid and energy were even more marked. OE induced further losses, especially of energy and lipid, but the differences between control and OE-treated rats in the HEA and QEA groups were relatively small, compared with AL. In fact, the similarities in body composition were higher when comparing the AL OE-treated rats with the HEA controls, and the HEA-OE rats with the Limited food intake and oleoyl-estrone MM Romero et al controls of the QEA. In any case, the overall effects of OE (ANOVA) over those of diet were significant for the combined energy content but not for protein or lipid. The energy balance is shown in Table 3 . Diet restriction, but not OE treatment, decreased energy expenditure, but to a lesser extent than changed energy intake, the difference being compensated by mobilisation of body energy substrates, mainly lipid, which accounted by 90-99% of energy accretion in all groups, the difference being the changes in protein stores. The maximal differences between energy intake, energy accretion and also calculated energy expenditure were found in the AL groups, there were no differences for energy balance figures between OE-treated and controls for the HEA and QEA groups.
The nitrogen balance is presented in Table 4 . There were no significant effects of OE on Na. Decreased Ni in all groups was counteracted by decreased N excretion. However, OE elicited a shift in the form in which N was excreted, with Limited food intake and oleoyl-estrone MM Romero et al lower faecal losses, partly compensated by non-faecal excretion, suggesting a higher ability to extract dietary N in the OE-treated animals. Table 5 presents the serum metabolites, enzymes and hormones of controls and OE-treated animals. Dietary restriction reduced the glucose levels, but the changes were smaller in the OE groups. Insulin levels decreased markedly with OE treatment in AL animals, but further diet restriction induced a more marked decrease in insulin levels in controls than in OE rats.
Urea levels decreased with diet restriction in controls, but not in OE-treated rats. Creatinine levels changed little, and thus the urea/creatinine (mol/mol) ratios were better maintained in all OE-treated rats (114, 135, 111, respectively, for AL, HEA and QEA groups) than in controls (156, 84, 92 for the corresponding groups), which suggests that under food restriction, the OE rats had a more active urea production than the untreated, in which it was reduced almost by half.
Dietary restriction markedly decreased serum triacylglycerols, and OE further decreased these levels; however, the increases on 3-hydroxybutyrate and NEFA were similar for matching OE/control food-restricted groups. Cholesterol levels were practically unchanged by dietary manipulation, but OE-induced marked, albeit similar, decreases irrespective of dietary status.
Aspartate transaminase did not show changes in any group; alanine transaminase levels were maximal in AL controls, with similar low levels in the other experimental groups.
Adiponectin levels showed no significant changes with dietary restriction, but the levels were lower in all OE-treated groups than in their matching controls. Leptin levels markedly decreased with either dietary restriction or OE treatment.
Discussion
The data presented suggest that no special advantages are gained by combining OE treatment and hypocaloric diets with respect to OE treatment alone, since the effects of both procedures are far from being additive. Notwithstanding, and in spite of OE deeply affecting food intake, mechanisms other than limited energy intake are responsible for the mobilisation of body fat, since food intake alone cannot explain the effects on body weight, nor, especially, the metabolite, cytokine and hormone changes observed in treated rats. In all cases, however, OE administration resulted in an improved metabolic homoeostasis: better maintained glycaemia, lower cholesterol and shallower hormonal changes, but at the expense of slightly increased protein metabolism.
OE treatment without the concourse of dietary restrictions protects body protein and carbohydrate, mobilising only fat.
11 This is accomplished essentially by facilitating the use of fatty acids by the muscle and other peripheral tissues, 13 decreasing the oxidation of glucose and increasing its storage as glycogen, 10 and, at the same time, decreasing insulin resistance. 11, 26 Under OE, glucose levels are maintained in spite of a marked decrease of insulin. 10, 11, 17 In food deprivation or restriction, glycaemia is maintained at the expense of 3C fragments, essentially derived from amino acids through the glucose-alanine cycle. 27 However, under OE treatment there is no need for an enhanced liver glucose output, since peripheral utilisation of glucose is decreased, 28 which results in the sparing of protein. 10, 11 However, when the rat is subjected to an additional and severe decrease in food available, the emergency mechanisms that maintain glycaemia are nevertheless activated. The higher sensitivity to insulin elicited by OE may result in enhanced hepatic gluconeogenesis, thus draining the 3C fragments available. As a consequence, more amino acids are mobilised in OEtreated rats than in food-deprived controls, since the former maintain better the glucose levels at the expense of higher amino-acid catabolism. The higher urea production (maintained urea/creatinine ratios) and the fractionally higher loss of body protein is not fully compensated by the also slightly higher nitrogen extraction from food. Thus, paradoxically, the combination of a protein-sparing agent, OE, 9,11 with a process that actively mobilises body protein as is food deprivation, 29 results in small increases in body protein mobilisation. The low levels of insulin cannot be used to explain this situation (i.e. a decreased anabolic signal may facilitate catabolism), since the rats not receiving OE showed even lower levels of insulin than those treated with OE; in addition, OE increases insulin sensitivity, 26 insulin is largely responsible for muscle protein integrity, and muscle contains the largest body protein stores. Glucose availability was maintained in all groups, since the increases in 3-hydroxybutyrate were small and easily correlated with the increased levels of NEFA. The characteristic effect of OE decreasing circulating cholesterol, 10,12 also observed here, is largely independent of the mobilisation of lipids (controls' levels practically did not change with dietary restriction), but is directly correlated with an enhanced lipoprotein metabolism. 12, 13 The marked effects of OE on leptin 10,12 hint at deeply altered adipocyte signalling pathways, the uncharacteristic decreases of adiponectin elicited by OE attest that there is no direct or easy explanation of the mobilising effects of OE. Adiponectin and leptin levels usually show reversed patterns, leptin levels being high in the obese, 30 which usually show low adiponectin concentrations. 31 Adiponectin may be a harbinger of increased insulin sensitivity, 32 but in the fooddeprived rats receiving OE, adiponectin, leptin and insulin levels were all decreased, under conditions of normoglycaemia, decreased appetite, maintained energy expenditure, and massive lipid mobilisation. This situation does not correspond with the usual paradigm of cytokine release by the adipocytes, 33 and may simply reflect increased OEinduced adipocyte apoptosis, 34 that eventually may result
Limited food intake and oleoyl-estrone MM Romero et al in diminished overall secretion of adipocyte-derived proteins into the bloodstream. The lack of changes in transaminases suggest that hepatic function is not compromised, independently of the higher protein mobilisation of semistarved OE-treated rats. This lack of hepatic damage agrees with previous findings in rats treated with OE. 35 The similitudes in body composition parameters of ad libitum-fed OE-treated rats with the untreated HEA animals contrasts with the marked discordances in plasma composition found between these same groups. Conversely, the relative mild differential effects of OE on body composition parameters of matched (control and OE-treated) fooddeprived groups sharply contrast with the marked OEinduced differences in plasma parameters, which suggests that, irrespective of the non-additive overall fat-mobilising effects of either diet restriction or OE treatment, the metabolic mechanisms through which these effects are elicited are basically different, as ascertained by the differences observed in serum composition patterns.
It is concluded that the combination of severe food restriction and OE treatment may result in unwanted increased protein mobilisation with no synergy between both procedures on weight loss.
